-
-
-
-
-
-
-
Neurocrine Bio. (NBIX) PT Raised to $185 at Morgan Stanley
-
-
-
-
-
-
-
4Q25/2026 Biotech Earnings Preview: RBC
-
-
-
-
-
-
-
Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2025 Financial Results
-
-
-
-
-
-
-
Neurocrine Biosciences Reports First Quarter 2025 Financial Results and Reaffirms 2025 Financial Guidance
-
-
-
-
-
-
-
Neurocrine Biosciences (NBIX) Tops Q3 EPS by 29c, Beats on Revenue; Offers FY24 Revenue Guidance
-
-
-
-
-
-
-
Neurocrine Biosciences (NBIX) Announces CEO Change
-
-
-
-
-
-
-
Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2023 Financial Results
-
1,197,441 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

